Prognostic significance of DNA flow cytometry in non-Hodgkin’s lymphoma

Abstract

A series of cases of non-Hodgkin’s lymphoma (NHL) were studied by morphology and flow cytometry. The DNA analysis was performed by applying a trypsin digestion method to archival paraffin-embedded samples. DNA aneuploid tumors constituted 47.4% of the total cases, and the frequency in the intermediate and the high malignant grade groups (51.9%, 76.8%) were significantly higher than that of the low grade group (17.696;P<0.05). The S phase fraction (SPF) increased significantly with a high histological malignant grade (P<0.005). The mean SPF values of the low, intermediate and high grade lympbomas were 6.5 (0.6–18.8)%, 13.5(3.2–37.3)% and 23.4 (4.4–41.4)%, respectively. Differences in ploidy status were not associated with survival rate. The survival rate of the cases with high SPF value in all cases of our series and low grade group of NHLs tended to become lower (P= 0.1 and 0.08, respectively). These results suggest that the flow cytometric analysis of DNA content should be a useful means for prediction of prognosis in non-Hodgkin’s lymphoma.

Keywords

non-Hodgkin’s lymphoma / flow cytometry / survival rate

References

[1] HedleyDW, et al.. Method for analysis of cellular DNA content of paraffin embedded pathological material using flow cytometry. J Histochem Cytochem, 1983, 31: 1333-1333

[2] The non-Hodgkin’s lymphoma pathologic classification project. National Cancer Institute sponsored study of classification of non-Hodgkin’s lymphoma. summary and discription of a working formulation for clinical usage. Cancer, 1982, 49: 2112-2112

[3] SchutteB, et al.. Flow cytometric determination of DNA ploidy level in nuclei isolated from paraffin embedded tissue. Cytometry, 1985, 6: 16-16

[4] VindelϕvLL, et al.. A detergent trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry, 1983, 3: 323-323

[5] FujikawaYK, et al.. A method for the cell cycle analysis by a microcomputer. J Kanazawa Med Univ, 1984, 9: 105-105

[6] FetoR, et al.. Design and analysis of randomized clinical trials requiring prolonged observation of each patientI Analysis and examples. Br J Cancer, 1977, 35: 1-1

[7] LehtinenT, et al.. Flow cytometric DNA analysis of 199 histologically favourable or unfavourable non-Hodgkin’s lymphomas. J Patho, 1989, 157: 27-27

[8] MorganDR, et al.. DNA content and prognosis in non-Hodgkin’s lymphoma. Br J Cancer, 1986, 54: 643-643